Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein 27 (HSP27) is a molecular chaperone belonging to the small heat shock protein family. It plays crucial roles in protein folding, antioxidant defense, and apoptosis inhibition. HSP27's expression is upregulated by various cellular stresses, and it is implicated in multiple diseases, including cancer, neurodegenerative disorders, cardiovascular diseases, and renal fibrosis. It is being explored as a therapeutic target, particularly in cancer, despite challenges in developing effective inhibitors.
Inhibition of HSP27 aims to disrupt its anti-apoptotic and pro-tumorigenic functions, often through interference with its oligomerization or phosphorylation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat Shock Protein 27 (HSP27).